

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 4.95088572 |
| 2 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.94125740 |
| 3 | sodium ion export (GO:0071436) | 4.40752146 |
| 4 | locomotory exploration behavior (GO:0035641) | 4.39749313 |
| 5 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.33170195 |
| 6 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.13137644 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.01497333 |
| 8 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.95117779 |
| 9 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.94861328 |
| 10 | response to muramyl dipeptide (GO:0032495) | 3.78296817 |
| 11 | cellular potassium ion homeostasis (GO:0030007) | 3.67728626 |
| 12 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.66549497 |
| 13 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.65312368 |
| 14 | regulation of ARF protein signal transduction (GO:0032012) | 3.63460949 |
| 15 | mannose metabolic process (GO:0006013) | 3.59815075 |
| 16 | cell communication by electrical coupling (GO:0010644) | 3.56074709 |
| 17 | retinal cone cell development (GO:0046549) | 3.54192111 |
| 18 | plasma membrane repair (GO:0001778) | 3.51369600 |
| 19 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.49598835 |
| 20 | germinal center formation (GO:0002467) | 3.45858692 |
| 21 | potassium ion import (GO:0010107) | 3.44918452 |
| 22 | response to peptidoglycan (GO:0032494) | 3.40844184 |
| 23 | cardiac myofibril assembly (GO:0055003) | 3.39349298 |
| 24 | synaptic vesicle exocytosis (GO:0016079) | 3.37785736 |
| 25 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.32988251 |
| 26 | glutamate secretion (GO:0014047) | 3.29140813 |
| 27 | activation of protein kinase A activity (GO:0034199) | 3.27501696 |
| 28 | cellular extravasation (GO:0045123) | 3.26171511 |
| 29 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.19658910 |
| 30 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.19593130 |
| 31 | cardiac muscle contraction (GO:0060048) | 3.16187881 |
| 32 | regulation of synapse structural plasticity (GO:0051823) | 3.13832191 |
| 33 | sarcomere organization (GO:0045214) | 3.13137809 |
| 34 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.12984339 |
| 35 | positive regulation of histone deacetylation (GO:0031065) | 3.12139790 |
| 36 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.09894356 |
| 37 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.08610713 |
| 38 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.08610713 |
| 39 | modulation by symbiont of host immune response (GO:0052553) | 3.08610713 |
| 40 | positive regulation by symbiont of host defense response (GO:0052509) | 3.08610713 |
| 41 | modulation by symbiont of host defense response (GO:0052031) | 3.08610713 |
| 42 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.08610713 |
| 43 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.08067576 |
| 44 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.06794513 |
| 45 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.05526572 |
| 46 | vocalization behavior (GO:0071625) | 3.04655847 |
| 47 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.03234771 |
| 48 | regulation of gamma-delta T cell activation (GO:0046643) | 3.02659099 |
| 49 | positive regulation of Rap GTPase activity (GO:0032854) | 3.02237160 |
| 50 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 3.00783181 |
| 51 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.98654862 |
| 52 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.98631435 |
| 53 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.98105241 |
| 54 | positive thymic T cell selection (GO:0045059) | 2.96829704 |
| 55 | rhodopsin mediated signaling pathway (GO:0016056) | 2.96442641 |
| 56 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.94720819 |
| 57 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.94720819 |
| 58 | response to laminar fluid shear stress (GO:0034616) | 2.93713745 |
| 59 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.91763903 |
| 60 | cell communication involved in cardiac conduction (GO:0086065) | 2.89197521 |
| 61 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.88955538 |
| 62 | myofibril assembly (GO:0030239) | 2.88675294 |
| 63 | negative regulation of cell size (GO:0045792) | 2.87934261 |
| 64 | macrophage activation involved in immune response (GO:0002281) | 2.87865819 |
| 65 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.87672047 |
| 66 | regulation of membrane repolarization (GO:0060306) | 2.84317240 |
| 67 | regulation of synaptic vesicle transport (GO:1902803) | 2.83460641 |
| 68 | negative regulation of cell killing (GO:0031342) | 2.83189199 |
| 69 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.83189199 |
| 70 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.81002378 |
| 71 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.80725685 |
| 72 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.78185544 |
| 73 | layer formation in cerebral cortex (GO:0021819) | 2.78047135 |
| 74 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.77891280 |
| 75 | regulation of Rap GTPase activity (GO:0032317) | 2.76171466 |
| 76 | B cell receptor signaling pathway (GO:0050853) | 2.75683043 |
| 77 | stress fiber assembly (GO:0043149) | 2.75142013 |
| 78 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.74339881 |
| 79 | detection of other organism (GO:0098543) | 2.73868775 |
| 80 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.73867913 |
| 81 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.72749817 |
| 82 | positive regulation of myotube differentiation (GO:0010831) | 2.71174368 |
| 83 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.70679203 |
| 84 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.70527672 |
| 85 | exploration behavior (GO:0035640) | 2.70507008 |
| 86 | regulation of leukocyte degranulation (GO:0043300) | 2.70013074 |
| 87 | regulation of ARF GTPase activity (GO:0032312) | 2.69306313 |
| 88 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.67522557 |
| 89 | striated muscle contraction (GO:0006941) | 2.66690380 |
| 90 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.65605113 |
| 91 | detection of bacterium (GO:0016045) | 2.64607033 |
| 92 | membrane repolarization (GO:0086009) | 2.64591989 |
| 93 | chemosensory behavior (GO:0007635) | 2.64555948 |
| 94 | neurotransmitter secretion (GO:0007269) | 2.63057003 |
| 95 | regulation of macrophage cytokine production (GO:0010935) | 2.62629712 |
| 96 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.62113282 |
| 97 | protein localization to synapse (GO:0035418) | 2.61996897 |
| 98 | thymic T cell selection (GO:0045061) | 2.61430909 |
| 99 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.61242364 |
| 100 | protein localization to endosome (GO:0036010) | 2.60821594 |
| 101 | regulation of cell communication by electrical coupling (GO:0010649) | 2.60476719 |
| 102 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.60257052 |
| 103 | regulation of necroptotic process (GO:0060544) | 2.59722904 |
| 104 | long-term memory (GO:0007616) | 2.59105646 |
| 105 | regulation of the force of heart contraction (GO:0002026) | 2.57430013 |
| 106 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.57015015 |
| 107 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.56720844 |
| 108 | cell-substrate adherens junction assembly (GO:0007045) | 2.56185200 |
| 109 | focal adhesion assembly (GO:0048041) | 2.56185200 |
| 110 | cellular sodium ion homeostasis (GO:0006883) | 2.56010218 |
| 111 | membrane depolarization during action potential (GO:0086010) | 2.55617733 |
| 112 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.55083513 |
| 113 | potassium ion homeostasis (GO:0055075) | 2.54221949 |
| 114 | positive regulation of protein dephosphorylation (GO:0035307) | 2.53926054 |
| 115 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.53441092 |
| 116 | positive regulation of sodium ion transport (GO:0010765) | 2.53188595 |
| 117 | actin-myosin filament sliding (GO:0033275) | 2.52988687 |
| 118 | muscle filament sliding (GO:0030049) | 2.52988687 |
| 119 | skeletal muscle contraction (GO:0003009) | 2.52153984 |
| 120 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.51218656 |
| 121 | regulation of mast cell degranulation (GO:0043304) | 2.51164219 |
| 122 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.50909017 |
| 123 | negative regulation of necroptotic process (GO:0060546) | 2.49402090 |
| 124 | B cell homeostasis (GO:0001782) | 2.48793294 |
| 125 | adaptation of signaling pathway (GO:0023058) | 2.48348350 |
| 126 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.48259372 |
| 127 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.47416334 |
| 128 | negative regulation of potassium ion transport (GO:0043267) | 2.46828296 |
| 129 | regulation of regulated secretory pathway (GO:1903305) | 2.46586080 |
| 130 | regulation of cation channel activity (GO:2001257) | 2.46529513 |
| 131 | positive regulation of synapse maturation (GO:0090129) | 2.45965421 |
| 132 | positive regulation of membrane potential (GO:0045838) | 2.45590650 |
| 133 | cellular response to epinephrine stimulus (GO:0071872) | 2.45567220 |
| 134 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.44413276 |
| 135 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.43966615 |
| 136 | proline transport (GO:0015824) | 2.43477531 |
| 137 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.42987799 |
| 138 | neutrophil activation involved in immune response (GO:0002283) | 2.41858770 |
| 139 | T cell selection (GO:0045058) | 2.41258593 |
| 140 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.41012205 |
| 141 | cellular response to fluid shear stress (GO:0071498) | 2.40158704 |
| 142 | regulation of postsynaptic membrane potential (GO:0060078) | 2.39024539 |
| 143 | peptidyl-threonine phosphorylation (GO:0018107) | 2.38753240 |
| 144 | embryonic process involved in female pregnancy (GO:0060136) | 2.37441837 |
| 145 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.37346346 |
| 146 | negative thymic T cell selection (GO:0045060) | 2.37047645 |
| 147 | dendritic spine morphogenesis (GO:0060997) | 2.36878520 |
| 148 | adherens junction assembly (GO:0034333) | 2.35946029 |
| 149 | negative regulation of type 2 immune response (GO:0002829) | 2.35893941 |
| 150 | positive regulation of cation channel activity (GO:2001259) | 2.35878462 |
| 151 | negative regulation of myotube differentiation (GO:0010832) | 2.35727722 |
| 152 | protein targeting to Golgi (GO:0000042) | 2.35641897 |
| 153 | regulation of ion transmembrane transporter activity (GO:0032412) | 2.35445103 |
| 154 | regulation of sodium ion transport (GO:0002028) | 2.35339689 |
| 155 | signal complex assembly (GO:0007172) | 2.35127038 |
| 156 | positive T cell selection (GO:0043368) | 2.33713642 |
| 157 | detection of external biotic stimulus (GO:0098581) | 2.28882367 |
| 158 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.26089586 |
| 159 | leukocyte aggregation (GO:0070486) | 2.25862860 |
| 160 | pinocytosis (GO:0006907) | 2.25819611 |
| 161 | negative regulation of interleukin-8 production (GO:0032717) | 2.25783474 |
| 162 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.22079329 |
| 163 | response to fluid shear stress (GO:0034405) | 2.21929061 |
| 164 | response to host (GO:0075136) | 2.21921914 |
| 165 | response to host defenses (GO:0052200) | 2.21921914 |
| 166 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.21921914 |
| 167 | histone H3-K36 demethylation (GO:0070544) | 2.21308723 |
| 168 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.21122120 |
| 169 | tolerance induction (GO:0002507) | 2.20886108 |
| 170 | negative regulation of granulocyte differentiation (GO:0030853) | 2.20533070 |
| 171 | detection of molecule of bacterial origin (GO:0032490) | 2.20521603 |
| 172 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.18162621 |
| 173 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.17811520 |
| 174 | negative regulation of T cell mediated immunity (GO:0002710) | 2.16246947 |
| 175 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.16065776 |
| 176 | negative T cell selection (GO:0043383) | 2.15911849 |
| 177 | positive regulation of B cell differentiation (GO:0045579) | 2.15873835 |
| 178 | regulation of necrotic cell death (GO:0010939) | 2.15252282 |
| 179 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.14894689 |
| 180 | neutrophil mediated immunity (GO:0002446) | 2.14495352 |
| 181 | activation of JUN kinase activity (GO:0007257) | 2.13864769 |
| 182 | activation of MAPKKK activity (GO:0000185) | 2.12155536 |
| 183 | regulation of lipid kinase activity (GO:0043550) | 2.11910352 |
| 184 | positive regulation of fibroblast migration (GO:0010763) | 2.10321548 |
| 185 | regulation of early endosome to late endosome transport (GO:2000641) | 2.10094866 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.95389977 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.87255795 |
| 3 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.86213849 |
| 4 | * MYC_22102868_ChIP-Seq_BL_Human | 2.83202735 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.83121074 |
| 6 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.69692922 |
| 7 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.61468527 |
| 8 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.60323985 |
| 9 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.56681992 |
| 10 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.52888810 |
| 11 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.34710956 |
| 12 | KDM2B_26808549_Chip-Seq_K562_Human | 2.23984599 |
| 13 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.12382723 |
| 14 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.07272834 |
| 15 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.02322414 |
| 16 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.98892227 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.97530988 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.95199636 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.94848793 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.93568836 |
| 21 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.92695676 |
| 22 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.90403738 |
| 23 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.88530325 |
| 24 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.88238042 |
| 25 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.88177299 |
| 26 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.84699729 |
| 27 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.83069718 |
| 28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.82805429 |
| 29 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.81483434 |
| 30 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.80494529 |
| 31 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.77988309 |
| 32 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.76532357 |
| 33 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.76007361 |
| 34 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.74774025 |
| 35 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.73783333 |
| 36 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.73148275 |
| 37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.68482952 |
| 38 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.66978119 |
| 39 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.66967608 |
| 40 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.66708243 |
| 41 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.65744642 |
| 42 | SPI1_23127762_ChIP-Seq_K562_Human | 1.65723789 |
| 43 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.61145260 |
| 44 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.58269392 |
| 45 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.55342361 |
| 46 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.54994989 |
| 47 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.52053482 |
| 48 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.52053482 |
| 49 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.51571869 |
| 50 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.50150718 |
| 51 | * MAF_26560356_Chip-Seq_TH2_Human | 1.49818200 |
| 52 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49267071 |
| 53 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.48885050 |
| 54 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.46879830 |
| 55 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.44902225 |
| 56 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.42245874 |
| 57 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.40067603 |
| 58 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.39158283 |
| 59 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.39158283 |
| 60 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.39050723 |
| 61 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.38309968 |
| 62 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.38208868 |
| 63 | MAF_26560356_Chip-Seq_TH1_Human | 1.35887977 |
| 64 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.34253764 |
| 65 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.32907039 |
| 66 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.29571226 |
| 67 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.29091828 |
| 68 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.29048457 |
| 69 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.28204075 |
| 70 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.27759536 |
| 71 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.27729391 |
| 72 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.27420609 |
| 73 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.27067701 |
| 74 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.26876427 |
| 75 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.26842756 |
| 76 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.26638986 |
| 77 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.26488048 |
| 78 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.26336778 |
| 79 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.23450595 |
| 80 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.23246430 |
| 81 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.22450511 |
| 82 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.21870094 |
| 83 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.19868462 |
| 84 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.19341702 |
| 85 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18244737 |
| 86 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.18069724 |
| 87 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.17362673 |
| 88 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.15965341 |
| 89 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14502340 |
| 90 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14271750 |
| 91 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.13970444 |
| 92 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.13956511 |
| 93 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.13553204 |
| 94 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.13439321 |
| 95 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.12871766 |
| 96 | P68_20966046_ChIP-Seq_HELA_Human | 1.11192520 |
| 97 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.10705821 |
| 98 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.10550928 |
| 99 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.10531054 |
| 100 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.09725965 |
| 101 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.08531836 |
| 102 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.07970635 |
| 103 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.07765626 |
| 104 | MYB_26560356_Chip-Seq_TH1_Human | 1.07715960 |
| 105 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07527879 |
| 106 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.06781017 |
| 107 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.06700081 |
| 108 | MYB_26560356_Chip-Seq_TH2_Human | 1.06475717 |
| 109 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05901760 |
| 110 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05460131 |
| 111 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.05357023 |
| 112 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.04804447 |
| 113 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.04381150 |
| 114 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.04289625 |
| 115 | * AR_19668381_ChIP-Seq_PC3_Human | 1.02328895 |
| 116 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02274026 |
| 117 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.02217510 |
| 118 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.01852799 |
| 119 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01643026 |
| 120 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01200088 |
| 121 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.99777761 |
| 122 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.98484755 |
| 123 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.97278406 |
| 124 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.97268639 |
| 125 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.95626504 |
| 126 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95061460 |
| 127 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.94312368 |
| 128 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.93963540 |
| 129 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.92568548 |
| 130 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.91654023 |
| 131 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.91038854 |
| 132 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.90949815 |
| 133 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.90026709 |
| 134 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89776525 |
| 135 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.88741397 |
| 136 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.88532568 |
| 137 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.88040408 |
| 138 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.87691611 |
| 139 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.87284314 |
| 140 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.87137115 |
| 141 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.86480972 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.72521442 |
| 2 | MP0000751_myopathy | 3.29742977 |
| 3 | MP0003436_decreased_susceptibility_to | 3.05684850 |
| 4 | MP0003646_muscle_fatigue | 2.88680527 |
| 5 | MP0008961_abnormal_basal_metabolism | 2.87579916 |
| 6 | MP0002837_dystrophic_cardiac_calcinosis | 2.77717472 |
| 7 | MP0005551_abnormal_eye_electrophysiolog | 2.66326839 |
| 8 | MP0004084_abnormal_cardiac_muscle | 2.63929132 |
| 9 | MP0005451_abnormal_body_composition | 2.63645437 |
| 10 | MP0003635_abnormal_synaptic_transmissio | 2.50162226 |
| 11 | MP0000749_muscle_degeneration | 2.36453881 |
| 12 | MP0004036_abnormal_muscle_relaxation | 2.34630206 |
| 13 | MP0004510_myositis | 2.31800303 |
| 14 | MP0004270_analgesia | 2.25541336 |
| 15 | MP0002909_abnormal_adrenal_gland | 2.22502171 |
| 16 | MP0004215_abnormal_myocardial_fiber | 2.17714886 |
| 17 | MP0004145_abnormal_muscle_electrophysio | 2.15257795 |
| 18 | MP0004130_abnormal_muscle_cell | 2.07683452 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.05851810 |
| 20 | MP0004233_abnormal_muscle_weight | 2.05216324 |
| 21 | * MP0004087_abnormal_muscle_fiber | 2.04274722 |
| 22 | MP0009780_abnormal_chondrocyte_physiolo | 1.99318330 |
| 23 | MP0002822_catalepsy | 1.98211564 |
| 24 | MP0001835_abnormal_antigen_presentation | 1.94121814 |
| 25 | MP0005330_cardiomyopathy | 1.87809318 |
| 26 | MP0002419_abnormal_innate_immunity | 1.86729541 |
| 27 | MP0008569_lethality_at_weaning | 1.84417155 |
| 28 | MP0003763_abnormal_thymus_physiology | 1.84017835 |
| 29 | MP0000685_abnormal_immune_system | 1.82791708 |
| 30 | MP0000747_muscle_weakness | 1.79920692 |
| 31 | MP0005423_abnormal_somatic_nervous | 1.76045611 |
| 32 | MP0008260_abnormal_autophagy | 1.75546450 |
| 33 | MP0002063_abnormal_learning/memory/cond | 1.72966561 |
| 34 | MP0002064_seizures | 1.70793124 |
| 35 | MP0003303_peritoneal_inflammation | 1.70173253 |
| 36 | MP0005000_abnormal_immune_tolerance | 1.69375714 |
| 37 | MP0009745_abnormal_behavioral_response | 1.68744835 |
| 38 | MP0002106_abnormal_muscle_physiology | 1.67154668 |
| 39 | MP0004947_skin_inflammation | 1.66804143 |
| 40 | MP0003724_increased_susceptibility_to | 1.66622766 |
| 41 | MP0004484_altered_response_of | 1.66367596 |
| 42 | MP0003091_abnormal_cell_migration | 1.66248469 |
| 43 | MP0001800_abnormal_humoral_immune | 1.64431355 |
| 44 | MP0005387_immune_system_phenotype | 1.63506255 |
| 45 | MP0001790_abnormal_immune_system | 1.63506255 |
| 46 | MP0006072_abnormal_retinal_apoptosis | 1.62533314 |
| 47 | MP0005025_abnormal_response_to | 1.62298103 |
| 48 | MP0002998_abnormal_bone_remodeling | 1.57798347 |
| 49 | MP0002269_muscular_atrophy | 1.56245378 |
| 50 | * MP0000759_abnormal_skeletal_muscle | 1.52406955 |
| 51 | MP0003191_abnormal_cellular_cholesterol | 1.51629238 |
| 52 | MP0000750_abnormal_muscle_regeneration | 1.49997201 |
| 53 | MP0003279_aneurysm | 1.49735968 |
| 54 | MP0005253_abnormal_eye_physiology | 1.48004140 |
| 55 | MP0004085_abnormal_heartbeat | 1.47956316 |
| 56 | MP0002396_abnormal_hematopoietic_system | 1.47791872 |
| 57 | * MP0005620_abnormal_muscle_contractility | 1.47547612 |
| 58 | * MP0010630_abnormal_cardiac_muscle | 1.46969733 |
| 59 | MP0005409_darkened_coat_color | 1.46417548 |
| 60 | MP0002420_abnormal_adaptive_immunity | 1.46310447 |
| 61 | MP0002090_abnormal_vision | 1.44703543 |
| 62 | MP0009840_abnormal_foam_cell | 1.44549629 |
| 63 | MP0003011_delayed_dark_adaptation | 1.44425863 |
| 64 | MP0001533_abnormal_skeleton_physiology | 1.44115651 |
| 65 | MP0002723_abnormal_immune_serum | 1.43520765 |
| 66 | MP0001819_abnormal_immune_cell | 1.43337805 |
| 67 | MP0003045_fibrosis | 1.42589332 |
| 68 | MP0002009_preneoplasia | 1.42387254 |
| 69 | MP0009046_muscle_twitch | 1.41748386 |
| 70 | MP0002452_abnormal_antigen_presenting | 1.41004518 |
| 71 | MP0005464_abnormal_platelet_physiology | 1.36945432 |
| 72 | MP0003300_gastrointestinal_ulcer | 1.36408054 |
| 73 | MP0002572_abnormal_emotion/affect_behav | 1.35882485 |
| 74 | MP0001958_emphysema | 1.32937283 |
| 75 | MP0001851_eye_inflammation | 1.32778814 |
| 76 | * MP0002972_abnormal_cardiac_muscle | 1.32754910 |
| 77 | MP0005369_muscle_phenotype | 1.31510523 |
| 78 | MP0003566_abnormal_cell_adhesion | 1.29683903 |
| 79 | MP0003137_abnormal_impulse_conducting | 1.24330671 |
| 80 | MP0002398_abnormal_bone_marrow | 1.23216053 |
| 81 | MP0004858_abnormal_nervous_system | 1.22493463 |
| 82 | MP0004185_abnormal_adipocyte_glucose | 1.22145909 |
| 83 | MP0003705_abnormal_hypodermis_morpholog | 1.19328699 |
| 84 | MP0000013_abnormal_adipose_tissue | 1.17585116 |
| 85 | MP0005166_decreased_susceptibility_to | 1.17305673 |
| 86 | MP0000716_abnormal_immune_system | 1.16230300 |
| 87 | MP0008438_abnormal_cutaneous_collagen | 1.14249911 |
| 88 | MP0008775_abnormal_heart_ventricle | 1.13776002 |
| 89 | MP0001544_abnormal_cardiovascular_syste | 1.13220878 |
| 90 | MP0005385_cardiovascular_system_phenoty | 1.13220878 |
| 91 | MP0000003_abnormal_adipose_tissue | 1.11876751 |
| 92 | MP0002272_abnormal_nervous_system | 1.11212602 |
| 93 | MP0002933_joint_inflammation | 1.09815888 |
| 94 | MP0003690_abnormal_glial_cell | 1.08657273 |
| 95 | MP0001486_abnormal_startle_reflex | 1.08448384 |
| 96 | MP0001968_abnormal_touch/_nociception | 1.06440024 |
| 97 | MP0003880_abnormal_central_pattern | 1.04626113 |
| 98 | MP0004811_abnormal_neuron_physiology | 1.04563058 |
| 99 | MP0002405_respiratory_system_inflammati | 1.04546498 |
| 100 | MP0005375_adipose_tissue_phenotype | 1.04412098 |
| 101 | MP0010155_abnormal_intestine_physiology | 1.04140036 |
| 102 | MP0008874_decreased_physiological_sensi | 1.04130439 |
| 103 | MP0003075_altered_response_to | 1.03903853 |
| 104 | MP0001501_abnormal_sleep_pattern | 1.03380662 |
| 105 | MP0003828_pulmonary_edema | 1.03328207 |
| 106 | MP0005671_abnormal_response_to | 1.03304939 |
| 107 | MP0002148_abnormal_hypersensitivity_rea | 1.00976102 |
| 108 | MP0005076_abnormal_cell_differentiation | 0.99386568 |
| 109 | MP0000733_abnormal_muscle_development | 0.99021639 |
| 110 | MP0004381_abnormal_hair_follicle | 0.98833390 |
| 111 | MP0002229_neurodegeneration | 0.98223181 |
| 112 | MP0001545_abnormal_hematopoietic_system | 0.97616535 |
| 113 | MP0005397_hematopoietic_system_phenotyp | 0.97616535 |
| 114 | MP0004808_abnormal_hematopoietic_stem | 0.97561072 |
| 115 | MP0000569_abnormal_digit_pigmentation | 0.97455768 |
| 116 | MP0001853_heart_inflammation | 0.97156580 |
| 117 | MP0001348_abnormal_lacrimal_gland | 0.96365754 |
| 118 | MP0000604_amyloidosis | 0.96084477 |
| 119 | MP0005386_behavior/neurological_phenoty | 0.95830038 |
| 120 | MP0004924_abnormal_behavior | 0.95830038 |
| 121 | MP0003633_abnormal_nervous_system | 0.93845558 |
| 122 | MP0002734_abnormal_mechanical_nocicepti | 0.93030799 |
| 123 | MP0009333_abnormal_splenocyte_physiolog | 0.91993615 |
| 124 | MP0003879_abnormal_hair_cell | 0.91672903 |
| 125 | MP0006082_CNS_inflammation | 0.90991661 |
| 126 | MP0004885_abnormal_endolymph | 0.90396723 |
| 127 | MP0002722_abnormal_immune_system | 0.90364204 |
| 128 | MP0002429_abnormal_blood_cell | 0.90200294 |
| 129 | MP0000767_abnormal_smooth_muscle | 0.89761791 |
| 130 | MP0005666_abnormal_adipose_tissue | 0.89577365 |
| 131 | MP0003172_abnormal_lysosome_physiology | 0.89436222 |
| 132 | MP0003950_abnormal_plasma_membrane | 0.89412210 |
| 133 | MP0000858_altered_metastatic_potential | 0.89072162 |
| 134 | MP0009785_altered_susceptibility_to | 0.88859481 |
| 135 | MP0001502_abnormal_circadian_rhythm | 0.85805596 |
| 136 | MP0003453_abnormal_keratinocyte_physiol | 0.85529567 |
| 137 | MP0002127_abnormal_cardiovascular_syste | 0.84103274 |
| 138 | MP0006138_congestive_heart_failure | 0.84067518 |
| 139 | MP0002234_abnormal_pharynx_morphology | 0.83772133 |
| 140 | MP0002067_abnormal_sensory_capabilities | 0.83600371 |
| 141 | MP0009278_abnormal_bone_marrow | 0.83561880 |
| 142 | MP0002882_abnormal_neuron_morphology | 0.81086332 |
| 143 | MP0010234_abnormal_vibrissa_follicle | 0.77637993 |
| 144 | MP0003329_amyloid_beta_deposits | 0.77608435 |
| 145 | MP0001970_abnormal_pain_threshold | 0.74984065 |
| 146 | MP0005195_abnormal_posterior_eye | 0.74153890 |
| 147 | MP0000703_abnormal_thymus_morphology | 0.72707732 |
| 148 | * MP0000266_abnormal_heart_morphology | 0.72628006 |
| 149 | MP0002332_abnormal_exercise_endurance | 0.71624577 |
| 150 | MP0002877_abnormal_melanocyte_morpholog | 0.71076892 |
| 151 | MP0002166_altered_tumor_susceptibility | 0.70339276 |
| 152 | MP0001440_abnormal_grooming_behavior | 0.70132059 |
| 153 | MP0003787_abnormal_imprinting | 0.69841433 |
| 154 | MP0002066_abnormal_motor_capabilities/c | 0.67068467 |
| 155 | MP0005623_abnormal_meninges_morphology | 0.65540725 |
| 156 | MP0010352_gastrointestinal_tract_polyps | 0.63743442 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 4.58097349 |
| 2 | Central scotoma (HP:0000603) | 4.32603785 |
| 3 | Nemaline bodies (HP:0003798) | 4.03639790 |
| 4 | Exercise-induced myalgia (HP:0003738) | 3.91526979 |
| 5 | Sudden death (HP:0001699) | 3.88510312 |
| 6 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.77946970 |
| 7 | Obstructive sleep apnea (HP:0002870) | 3.61606752 |
| 8 | Scotoma (HP:0000575) | 3.51465672 |
| 9 | Dysmetric saccades (HP:0000641) | 3.51281357 |
| 10 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.33124825 |
| 11 | Exercise-induced muscle cramps (HP:0003710) | 3.30110890 |
| 12 | Dyschromatopsia (HP:0007641) | 3.26004940 |
| 13 | Visual hallucinations (HP:0002367) | 3.21545557 |
| 14 | Distal lower limb muscle weakness (HP:0009053) | 3.18260592 |
| 15 | Bundle branch block (HP:0011710) | 3.14951515 |
| 16 | Difficulty running (HP:0009046) | 3.14947782 |
| 17 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.03894933 |
| 18 | Eczematoid dermatitis (HP:0000976) | 3.01692777 |
| 19 | Hyporeflexia of lower limbs (HP:0002600) | 2.98659600 |
| 20 | Ventricular fibrillation (HP:0001663) | 2.96943092 |
| 21 | Calf muscle hypertrophy (HP:0008981) | 2.95622305 |
| 22 | Abnormality of macular pigmentation (HP:0008002) | 2.93635034 |
| 23 | Atrial fibrillation (HP:0005110) | 2.89885296 |
| 24 | Prolonged QT interval (HP:0001657) | 2.85030093 |
| 25 | Primary atrial arrhythmia (HP:0001692) | 2.81137532 |
| 26 | Round ear (HP:0100830) | 2.76379240 |
| 27 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.75402421 |
| 28 | Pigmentary retinal degeneration (HP:0001146) | 2.74834095 |
| 29 | Abnormality of the calf musculature (HP:0001430) | 2.72817391 |
| 30 | Myokymia (HP:0002411) | 2.72751573 |
| 31 | Macroorchidism (HP:0000053) | 2.72123868 |
| 32 | Subaortic stenosis (HP:0001682) | 2.69659482 |
| 33 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.69659482 |
| 34 | Myopathic facies (HP:0002058) | 2.69480125 |
| 35 | Ulnar deviation of the wrist (HP:0003049) | 2.65665556 |
| 36 | Focal motor seizures (HP:0011153) | 2.65358122 |
| 37 | Focal seizures (HP:0007359) | 2.65094353 |
| 38 | Supraventricular tachycardia (HP:0004755) | 2.64421538 |
| 39 | Supraventricular arrhythmia (HP:0005115) | 2.58744186 |
| 40 | EMG: myopathic abnormalities (HP:0003458) | 2.54281910 |
| 41 | Syncope (HP:0001279) | 2.53128371 |
| 42 | Muscle fiber splitting (HP:0003555) | 2.49442682 |
| 43 | Asymmetric septal hypertrophy (HP:0001670) | 2.46862514 |
| 44 | Genetic anticipation (HP:0003743) | 2.44048803 |
| 45 | Ventricular tachycardia (HP:0004756) | 2.43852536 |
| 46 | Papilloma (HP:0012740) | 2.42902559 |
| 47 | Verrucae (HP:0200043) | 2.42902559 |
| 48 | Abnormal EKG (HP:0003115) | 2.40181349 |
| 49 | Myotonia (HP:0002486) | 2.37046584 |
| 50 | Increased IgE level (HP:0003212) | 2.37014862 |
| 51 | Hyperacusis (HP:0010780) | 2.34806954 |
| 52 | Distal arthrogryposis (HP:0005684) | 2.33323819 |
| 53 | Type 1 muscle fiber predominance (HP:0003803) | 2.31718043 |
| 54 | Depression (HP:0000716) | 2.30534148 |
| 55 | Increased variability in muscle fiber diameter (HP:0003557) | 2.28540660 |
| 56 | Abnormality of the fingertips (HP:0001211) | 2.28408914 |
| 57 | Lower limb amyotrophy (HP:0007210) | 2.26309201 |
| 58 | Pendular nystagmus (HP:0012043) | 2.26218355 |
| 59 | Frequent falls (HP:0002359) | 2.24424210 |
| 60 | Spontaneous hematomas (HP:0007420) | 2.24336669 |
| 61 | Abnormal social behavior (HP:0012433) | 2.22982835 |
| 62 | Impaired social interactions (HP:0000735) | 2.22982835 |
| 63 | Myoglobinuria (HP:0002913) | 2.21341469 |
| 64 | Posterior subcapsular cataract (HP:0007787) | 2.20871649 |
| 65 | Broad face (HP:0000283) | 2.19303580 |
| 66 | Increased connective tissue (HP:0009025) | 2.17973918 |
| 67 | Abnormality of binocular vision (HP:0011514) | 2.17757843 |
| 68 | Diplopia (HP:0000651) | 2.17757843 |
| 69 | Recurrent abscess formation (HP:0002722) | 2.17747741 |
| 70 | Difficulty climbing stairs (HP:0003551) | 2.17575985 |
| 71 | Abnormality of macrophages (HP:0004311) | 2.17404499 |
| 72 | Abnormality of the lower motor neuron (HP:0002366) | 2.16869747 |
| 73 | Postural instability (HP:0002172) | 2.15675650 |
| 74 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.15613473 |
| 75 | Heart block (HP:0012722) | 2.14215644 |
| 76 | Neck muscle weakness (HP:0000467) | 2.13754351 |
| 77 | Ventricular arrhythmia (HP:0004308) | 2.13515266 |
| 78 | Cerebral aneurysm (HP:0004944) | 2.13369833 |
| 79 | Recurrent bacterial skin infections (HP:0005406) | 2.12277560 |
| 80 | Papilledema (HP:0001085) | 2.11874120 |
| 81 | Rapidly progressive (HP:0003678) | 2.11136553 |
| 82 | Truncal ataxia (HP:0002078) | 2.10846738 |
| 83 | Vertebral arch anomaly (HP:0008438) | 2.10793155 |
| 84 | Amyloidosis (HP:0011034) | 2.09934131 |
| 85 | Epileptic encephalopathy (HP:0200134) | 2.08632587 |
| 86 | Spondylolisthesis (HP:0003302) | 2.08208199 |
| 87 | Action tremor (HP:0002345) | 2.07763494 |
| 88 | Atrioventricular block (HP:0001678) | 2.07025510 |
| 89 | Colitis (HP:0002583) | 2.06436836 |
| 90 | Dysdiadochokinesis (HP:0002075) | 2.06086360 |
| 91 | Distal lower limb amyotrophy (HP:0008944) | 2.05816342 |
| 92 | Chorioretinal atrophy (HP:0000533) | 2.05410735 |
| 93 | Poor eye contact (HP:0000817) | 2.04925390 |
| 94 | Hemiplegia (HP:0002301) | 2.02586069 |
| 95 | EMG: neuropathic changes (HP:0003445) | 2.02437296 |
| 96 | Dysostosis multiplex (HP:0000943) | 2.01498035 |
| 97 | Abnormal atrioventricular conduction (HP:0005150) | 2.01420850 |
| 98 | Neoplasm of the heart (HP:0100544) | 1.99843867 |
| 99 | Bulbar palsy (HP:0001283) | 1.98052975 |
| 100 | Type II diabetes mellitus (HP:0005978) | 1.97647125 |
| 101 | Supranuclear gaze palsy (HP:0000605) | 1.97055027 |
| 102 | Aortic aneurysm (HP:0004942) | 1.95991145 |
| 103 | Foot dorsiflexor weakness (HP:0009027) | 1.95525911 |
| 104 | Protrusio acetabuli (HP:0003179) | 1.95498257 |
| 105 | Myositis (HP:0100614) | 1.94605990 |
| 106 | Distal upper limb amyotrophy (HP:0007149) | 1.94576152 |
| 107 | Upper limb amyotrophy (HP:0009129) | 1.94576152 |
| 108 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.94460382 |
| 109 | Muscle stiffness (HP:0003552) | 1.94373550 |
| 110 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.93174384 |
| 111 | Impaired smooth pursuit (HP:0007772) | 1.91533033 |
| 112 | Slow saccadic eye movements (HP:0000514) | 1.91225241 |
| 113 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.90099336 |
| 114 | Pointed chin (HP:0000307) | 1.89784381 |
| 115 | Progressive cerebellar ataxia (HP:0002073) | 1.89092358 |
| 116 | Cellulitis (HP:0100658) | 1.88720680 |
| 117 | Neuronal loss in central nervous system (HP:0002529) | 1.88491087 |
| 118 | Broad-based gait (HP:0002136) | 1.87265290 |
| 119 | Muscle fiber inclusion bodies (HP:0100299) | 1.86915421 |
| 120 | Fatigue (HP:0012378) | 1.86556348 |
| 121 | Slender build (HP:0001533) | 1.86039113 |
| 122 | Febrile seizures (HP:0002373) | 1.85726511 |
| 123 | Absence seizures (HP:0002121) | 1.85582640 |
| 124 | Gastrointestinal stroma tumor (HP:0100723) | 1.85240413 |
| 125 | Agammaglobulinemia (HP:0004432) | 1.85048515 |
| 126 | Abnormality of the foot musculature (HP:0001436) | 1.84961659 |
| 127 | Rhabdomyolysis (HP:0003201) | 1.84518235 |
| 128 | Limb-girdle muscle atrophy (HP:0003797) | 1.84443149 |
| 129 | Aneurysm (HP:0002617) | 1.84442530 |
| 130 | Interstitial pulmonary disease (HP:0006530) | 1.83966721 |
| 131 | Meningitis (HP:0001287) | 1.82960791 |
| 132 | Achilles tendon contracture (HP:0001771) | 1.82634302 |
| 133 | Gingivitis (HP:0000230) | 1.81777877 |
| 134 | Ankle clonus (HP:0011448) | 1.81403808 |
| 135 | Mediastinal lymphadenopathy (HP:0100721) | 1.81359506 |
| 136 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.80867227 |
| 137 | Easy fatigability (HP:0003388) | 1.78597008 |
| 138 | Chest pain (HP:0100749) | 1.77901596 |
| 139 | Recurrent fungal infections (HP:0002841) | 1.77749778 |
| 140 | Hypercortisolism (HP:0001578) | 1.77546694 |
| 141 | Gastrointestinal inflammation (HP:0004386) | 1.77148934 |
| 142 | Annular pancreas (HP:0001734) | 1.74391012 |
| 143 | Enlarged penis (HP:0000040) | 1.73341403 |
| 144 | Increased cerebral lipofuscin (HP:0011813) | 1.72608954 |
| 145 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.71625954 |
| 146 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.71263133 |
| 147 | Emphysema (HP:0002097) | 1.70745710 |
| 148 | Inflammation of the large intestine (HP:0002037) | 1.70448999 |
| 149 | Prolonged bleeding time (HP:0003010) | 1.69959138 |
| 150 | Onion bulb formation (HP:0003383) | 1.69504526 |
| 151 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.68640165 |
| 152 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.68080539 |
| 153 | Recurrent cutaneous fungal infections (HP:0011370) | 1.66597639 |
| 154 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.66597639 |
| 155 | Dilatation of the ascending aorta (HP:0005111) | 1.66026253 |
| 156 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.65742986 |
| 157 | Polycythemia (HP:0001901) | 1.65467234 |
| 158 | Restrictive lung disease (HP:0002091) | 1.65297054 |
| 159 | Polygenic inheritance (HP:0010982) | 1.65282063 |
| 160 | Spinal rigidity (HP:0003306) | 1.64815514 |
| 161 | Recurrent viral infections (HP:0004429) | 1.64583048 |
| 162 | Neurofibrillary tangles (HP:0002185) | 1.63069380 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.40069997 |
| 2 | MAP3K10 | 3.34083568 |
| 3 | PKN2 | 2.71373501 |
| 4 | MAP3K9 | 2.40683765 |
| 5 | SIK2 | 2.29753505 |
| 6 | EEF2K | 2.25850404 |
| 7 | TTN | 2.17264663 |
| 8 | DMPK | 2.11018599 |
| 9 | ERN1 | 2.09006822 |
| 10 | CDK12 | 2.00579029 |
| 11 | TAOK1 | 1.99433206 |
| 12 | PRKD3 | 1.93483461 |
| 13 | NTRK3 | 1.88783166 |
| 14 | MAP4K1 | 1.88736033 |
| 15 | CAMKK1 | 1.85947621 |
| 16 | MAP3K7 | 1.84858629 |
| 17 | RIPK1 | 1.77286342 |
| 18 | KSR2 | 1.60147163 |
| 19 | PRKCH | 1.56049582 |
| 20 | EPHA4 | 1.55563444 |
| 21 | CAMK1G | 1.54788404 |
| 22 | PAK6 | 1.53138363 |
| 23 | PHKG2 | 1.49780894 |
| 24 | PHKG1 | 1.49780894 |
| 25 | GRK6 | 1.39934857 |
| 26 | TYK2 | 1.39009446 |
| 27 | STK38 | 1.37831058 |
| 28 | MAP3K14 | 1.32714534 |
| 29 | BLK | 1.32552329 |
| 30 | ALK | 1.32531920 |
| 31 | SMG1 | 1.32482183 |
| 32 | DAPK2 | 1.27102371 |
| 33 | MARK2 | 1.25928889 |
| 34 | FES | 1.25821697 |
| 35 | TBK1 | 1.24760964 |
| 36 | PIK3CG | 1.24264976 |
| 37 | MAP3K4 | 1.18142054 |
| 38 | TYRO3 | 1.15588265 |
| 39 | MAP3K3 | 1.15267531 |
| 40 | MAP3K13 | 1.14693318 |
| 41 | RIPK4 | 1.13832124 |
| 42 | TAOK2 | 1.13425478 |
| 43 | CAMK1 | 1.13114779 |
| 44 | SGK3 | 1.11554462 |
| 45 | CAMK1D | 1.05105575 |
| 46 | PDK1 | 1.04680386 |
| 47 | CAMK4 | 1.03024952 |
| 48 | RET | 1.02300582 |
| 49 | STK11 | 1.00194901 |
| 50 | LMTK2 | 0.99285948 |
| 51 | HIPK2 | 0.98800504 |
| 52 | PRKD2 | 0.98510932 |
| 53 | IRAK4 | 0.98411212 |
| 54 | ICK | 0.95840443 |
| 55 | KIT | 0.92757134 |
| 56 | MAP3K11 | 0.92322742 |
| 57 | OBSCN | 0.92110680 |
| 58 | MINK1 | 0.90266983 |
| 59 | MAP2K4 | 0.88722473 |
| 60 | MOS | 0.88291489 |
| 61 | CSK | 0.87948005 |
| 62 | PRKD1 | 0.87929986 |
| 63 | WNK1 | 0.87013992 |
| 64 | NTRK2 | 0.87002587 |
| 65 | IRAK3 | 0.86235435 |
| 66 | MAP3K1 | 0.85875715 |
| 67 | CDC42BPA | 0.84464413 |
| 68 | FGFR3 | 0.82610864 |
| 69 | GRK1 | 0.81999581 |
| 70 | SIK1 | 0.80142532 |
| 71 | TRPM7 | 0.79777322 |
| 72 | * MAPK7 | 0.78646301 |
| 73 | FGFR4 | 0.77641385 |
| 74 | PDGFRA | 0.76830999 |
| 75 | NEK1 | 0.76596883 |
| 76 | BTK | 0.76588889 |
| 77 | TNK2 | 0.76194228 |
| 78 | IRAK2 | 0.75841260 |
| 79 | SYK | 0.74581777 |
| 80 | JAK1 | 0.74328874 |
| 81 | PDPK1 | 0.74088183 |
| 82 | PTK6 | 0.72444961 |
| 83 | IKBKE | 0.71360053 |
| 84 | HCK | 0.70337327 |
| 85 | * CDK5 | 0.68075045 |
| 86 | GRK5 | 0.67634661 |
| 87 | ARAF | 0.67326788 |
| 88 | MAPK11 | 0.66423537 |
| 89 | MAP3K6 | 0.66391962 |
| 90 | JAK3 | 0.65621473 |
| 91 | MAP3K2 | 0.64227164 |
| 92 | MAPK4 | 0.64157761 |
| 93 | PINK1 | 0.63743758 |
| 94 | RPS6KC1 | 0.63713287 |
| 95 | RPS6KL1 | 0.63713287 |
| 96 | MAP2K3 | 0.63021820 |
| 97 | NTRK1 | 0.62210884 |
| 98 | PRPF4B | 0.61998457 |
| 99 | CAMKK2 | 0.60909608 |
| 100 | PAK3 | 0.59557076 |
| 101 | LRRK2 | 0.59488233 |
| 102 | KSR1 | 0.57831772 |
| 103 | DAPK1 | 0.56729734 |
| 104 | MTOR | 0.56068856 |
| 105 | PTK2B | 0.55538940 |
| 106 | PDGFRB | 0.55107401 |
| 107 | SGK1 | 0.53206426 |
| 108 | ITK | 0.53099144 |
| 109 | SGK2 | 0.52949841 |
| 110 | DYRK1B | 0.50958924 |
| 111 | RPS6KA2 | 0.49647732 |
| 112 | LATS2 | 0.49615368 |
| 113 | TGFBR2 | 0.49442413 |
| 114 | MARK3 | 0.48121157 |
| 115 | UHMK1 | 0.48105579 |
| 116 | PRKAA1 | 0.48020244 |
| 117 | SGK494 | 0.47209885 |
| 118 | SGK223 | 0.47209885 |
| 119 | * MAPK12 | 0.47081047 |
| 120 | RPS6KA6 | 0.45709613 |
| 121 | FYN | 0.44653140 |
| 122 | * RPS6KA3 | 0.44559452 |
| 123 | ZAP70 | 0.44345630 |
| 124 | BMX | 0.44276333 |
| 125 | RAF1 | 0.43506053 |
| 126 | NEK9 | 0.42510702 |
| 127 | JAK2 | 0.42335820 |
| 128 | BRD4 | 0.42213446 |
| 129 | EPHB1 | 0.41016527 |
| 130 | SCYL2 | 0.40653671 |
| 131 | FGFR2 | 0.39054348 |
| 132 | MAPK10 | 0.36627394 |
| 133 | SIK3 | 0.35558161 |
| 134 | CSF1R | 0.35029180 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 3.56554446 |
| 2 | Olfactory transduction_Homo sapiens_hsa04740 | 2.16501932 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 1.89877026 |
| 4 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.85800369 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 1.84951987 |
| 6 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.82399431 |
| 7 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.80338125 |
| 8 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.79434377 |
| 9 | Other glycan degradation_Homo sapiens_hsa00511 | 1.71162879 |
| 10 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.70413012 |
| 11 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.60410782 |
| 12 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.59457340 |
| 13 | Insulin secretion_Homo sapiens_hsa04911 | 1.59357075 |
| 14 | Morphine addiction_Homo sapiens_hsa05032 | 1.55614792 |
| 15 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.53410291 |
| 16 | Salivary secretion_Homo sapiens_hsa04970 | 1.51747493 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.51205933 |
| 18 | GABAergic synapse_Homo sapiens_hsa04727 | 1.50724165 |
| 19 | Leishmaniasis_Homo sapiens_hsa05140 | 1.49641915 |
| 20 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.46681386 |
| 21 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.44873103 |
| 22 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.40728817 |
| 23 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.40074913 |
| 24 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.39817795 |
| 25 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.38047599 |
| 26 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.34582723 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.34193324 |
| 28 | Renin secretion_Homo sapiens_hsa04924 | 1.33237864 |
| 29 | Glioma_Homo sapiens_hsa05214 | 1.31430906 |
| 30 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.30209411 |
| 31 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.28847104 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.28333643 |
| 33 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.26184859 |
| 34 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.26044334 |
| 35 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.22498299 |
| 36 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.21686355 |
| 37 | Tuberculosis_Homo sapiens_hsa05152 | 1.20169038 |
| 38 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.18624793 |
| 39 | Nicotine addiction_Homo sapiens_hsa05033 | 1.16964897 |
| 40 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.15932728 |
| 41 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.14080516 |
| 42 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.13816886 |
| 43 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.12890271 |
| 44 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.12602989 |
| 45 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.10893760 |
| 46 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.09516785 |
| 47 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.09230092 |
| 48 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.09012367 |
| 49 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.07532238 |
| 50 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.06484771 |
| 51 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.05013727 |
| 52 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.01257356 |
| 53 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.00950546 |
| 54 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.00923363 |
| 55 | Hepatitis B_Homo sapiens_hsa05161 | 1.00843224 |
| 56 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.00521605 |
| 57 | Influenza A_Homo sapiens_hsa05164 | 0.99617950 |
| 58 | Amoebiasis_Homo sapiens_hsa05146 | 0.99567698 |
| 59 | Cocaine addiction_Homo sapiens_hsa05030 | 0.99217170 |
| 60 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.98619227 |
| 61 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.96610255 |
| 62 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.94453572 |
| 63 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.94258177 |
| 64 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.94249363 |
| 65 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.94229374 |
| 66 | Insulin resistance_Homo sapiens_hsa04931 | 0.94216238 |
| 67 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.94021921 |
| 68 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.92551046 |
| 69 | Long-term depression_Homo sapiens_hsa04730 | 0.92124643 |
| 70 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.91907872 |
| 71 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91710429 |
| 72 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.90754310 |
| 73 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.89698489 |
| 74 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.89658719 |
| 75 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.88208459 |
| 76 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.88128760 |
| 77 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.87959519 |
| 78 | Gap junction_Homo sapiens_hsa04540 | 0.87616861 |
| 79 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.87592353 |
| 80 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.86292005 |
| 81 | Malaria_Homo sapiens_hsa05144 | 0.84931483 |
| 82 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.83709368 |
| 83 | Platelet activation_Homo sapiens_hsa04611 | 0.83454520 |
| 84 | Hepatitis C_Homo sapiens_hsa05160 | 0.81500123 |
| 85 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.81475101 |
| 86 | Prion diseases_Homo sapiens_hsa05020 | 0.80778888 |
| 87 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.80048814 |
| 88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.79452640 |
| 89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.79127372 |
| 90 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.78208393 |
| 91 | Measles_Homo sapiens_hsa05162 | 0.78064858 |
| 92 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.77681682 |
| 93 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.77659075 |
| 94 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.77565907 |
| 95 | Endometrial cancer_Homo sapiens_hsa05213 | 0.77534652 |
| 96 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.75648928 |
| 97 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.75622432 |
| 98 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.75355889 |
| 99 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.75194898 |
| 100 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.74477186 |
| 101 | Circadian rhythm_Homo sapiens_hsa04710 | 0.74424377 |
| 102 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.74398792 |
| 103 | Bladder cancer_Homo sapiens_hsa05219 | 0.74177292 |
| 104 | Pertussis_Homo sapiens_hsa05133 | 0.73470691 |
| 105 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.73466698 |
| 106 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.72827434 |
| 107 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.71098276 |
| 108 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.69639810 |
| 109 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.69147719 |
| 110 | Melanogenesis_Homo sapiens_hsa04916 | 0.67085266 |
| 111 | Apoptosis_Homo sapiens_hsa04210 | 0.67048196 |
| 112 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.66973025 |
| 113 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.66915771 |
| 114 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.66483018 |
| 115 | Allograft rejection_Homo sapiens_hsa05330 | 0.65799602 |
| 116 | Taste transduction_Homo sapiens_hsa04742 | 0.65281271 |
| 117 | Prostate cancer_Homo sapiens_hsa05215 | 0.64737825 |
| 118 | Endocytosis_Homo sapiens_hsa04144 | 0.63994292 |
| 119 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.63943921 |
| 120 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.63752055 |
| 121 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.63255735 |
| 122 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.62503312 |
| 123 | Lysine degradation_Homo sapiens_hsa00310 | 0.62334294 |
| 124 | Focal adhesion_Homo sapiens_hsa04510 | 0.62149274 |
| 125 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.61373942 |
| 126 | Viral myocarditis_Homo sapiens_hsa05416 | 0.59520447 |
| 127 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.57362907 |
| 128 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.56625937 |
| 129 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.56501053 |
| 130 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.56191622 |
| 131 | Colorectal cancer_Homo sapiens_hsa05210 | 0.55844300 |
| 132 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.55199008 |
| 133 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.55022887 |

